Health Tech Coverage - MedCity News
This week at HLTH, FDA Commissioner Robert Califf discussed the current state of healthcare AI. He talked about some of the qualms he has, such as his worry that AI is worsening health inequities ...
Safe and Affordable Family-Forming Benefits Provide a …
Feb 16, 2024 · Contemporary households reflect the evolving tapestry of society, embracing the diversity of same-sex partnerships, single parenthood, and professional women choosing to embark on parenthood later ...
Clinical Trials - MedCity News
The FDA had asked Biogen and Sage Therapeutics to provide more clinical data supporting Zurzuvae in major depressive disorder. Citing the time and expense of additional clinical trials, the ...
Marissa Plescia, Author at MedCity News
Marissa Plescia is a reporter for MedCity News covering payers, employers and health tech. She previously worked at Becker’s Hospital Review as a finance reporter. Before that, she was a data ...
Katie Adams, Author at MedCity News
Katie Adams is a senior reporter for MedCity News covering providers and healthcare technology. Previously, she worked as a healthcare technology editor at Becker’s Hospital Review. Her ...
Roivant extends AI drug discovery reach with $450M Silicon …
Feb 26, 2021 · New York and Basel, Switzerland-based Roivant is acquiring Silicon Therapeutics, a computational drug discovery startup that has advanced from company launch to clinical testing in four years ...
Policy Coverage - MedCity News
CMS recently finalized the Patient Safety Structural Measure, which sets forth a broad roadmap for the implementation of a culture of safety, learning, transparency and accountability within ...
Kaiser Coverage - MedCity News
A California law signed Oct. 8 by Gov. Gavin Newsom requires that mental health and substance abuse patients be offered return appointments no more than 10 days after a previous session, unless ...
digital mental health Coverage - MedCity News
Digital tech for mental care grows as way to help patients navigate health deserts. The need for mental health services continues to strain the ability of the healthcare system to respond. New ...
Translarna Coverage - MedCity News
European Commission Decision Is a Reprieve for PTC Therapeutics’ Rare Muscle Disease Drug The PTC Therapeutics drug Translarna failed its confirmatory study in Duchenne muscular dystrophy.
- Some results have been removed